A study has found that SLC7A11 is up regulated in a variety of tumor cells, promotes glutathione (GSH) synthesis to inhibit damage from oxidative stress to tumor cells, and is negatively correlated with the median OS of patients (78). The gene discussed is SLC7A11; the disease is neoplasm.